ASHEcon 2025: The Annual Conference of the American Society of Health Economists

Share

This four-day event features panel discussions and contributed sessions on the latest developments in health economics research.

Cornerstone Research staff and affiliated experts will attend the Annual Conference of the American Society of Health Economists (ASHEcon) in Nashville to speak in plenary sessions, present original research, and share insights on the economics of health care.

Laurence Baker, Stanford University

23 June

  • (Presenting Author) Abstract: “Effects of Integrating Primary Care and Specialist Physician Practices”

24 June

  • (Presenter) Session: “Being a Health Economist: Working in Different Types of Departments and Schools,” 1:45 PM–3:15 PM
  • (Presenting Author) Abstract: “Effects of the Part D Low Income Subsidy on Drug Utilization and Health”
M. Kate Bundorf, Duke University

23 June

  • (Author) Abstract: “Effects of Integrating Primary Care and Specialist Physician Practices”
  • (Chair) Emerging Scholars Session: “Effects of Health Insurance and Consumer Decision Making”

24 June

  • (Discussant) Abstract: “Insurer-Primary Care Integration and Patient Steering in the Medicare Advantage Market”
  • (Chair) Emerging Scholars Session: “Competition in Health Care Markets”

25 June

  • (Chair) Session: “The Effect of Public Health Insurance Expansion: From Youth to the Golden Years”
  • (Chair) Session: “The Economics of Medical Careers: Gender, Policy, and Pandemic Effects”
  • (Author) Abstract: “Who Chooses a Career in Medicine? The Impact of the COVID-19 Pandemic on Medical School Applications in China”
  • (Discussant) Abstract: “Health Womanpower: The Role of Federal Policy in Women’s Entry into Medicine”
  • (Discussant) Abstract: “Aging Out of Parental Insurance: Shifts in Insurance Status, Hospital Utilization, and the Role of Medicaid Expansion”
Caitlyn Fleming, Cornerstone Research

June 23

  • (Presenter) Session: “Being a Health Economist: Working in Government, Health Insurance and Health Plans, Pharmaceutical Companies, Consulting Firms and Think Tanks,” 8:30 AM–10:00 AM
Gautam Gowrisankaran, Columbia University

25 June

  • (Author) Abstract: “The Anatomy of Hospital Quality in the Treatment of COVID-19”
 Darius Lakdawalla, University of Southern California

24 June

  • (Author) Abstract: “Implications of Prospect Theory for Consumers’ Valuation of Novel Health Technologies”
  • (Author) Abstract: “Equity Consequences of Semaglutide Access Disparities”
Sean Nicholson, Cornell University

23 June

  • (Chair) Session: “Healthcare Provider Behaviour”
Maria Polyakova, Stanford University

23 June

  • (Discussant) Abstract: “In Defense of the Middleman: Quality Failures in the Generic Pharmaceutical Market”
  • (Discussant) Abstract: “Costs of Technological Frictions: Evidence from EHR (Non-)Interoperability”

24 June

  • (Author) Abstract: “Effects of the Part D Low Income Subsidy on Drug Utilization and Health”

25 June

  • (Author) Abstract: “Health Insurance as Economic Stimulus? Evidence from Long-Term Care Jobs”
Michael Richards, Cornell University

23 June

  • (Author) Abstract: “Managing Margins: PE Effects on Financial, Physical, and Human Capital”

24 June

  • (Author) Abstract: “Owning the Agent: Hospital Influence on Physician Behaviors”
  • (Author) Abstract: “High-Skill Trainees: Evidence from Residency Debuts”
Amanda Starc, Northwestern University

23 June

  • (Presenting Author) Abstract: “Painful Bargaining: Evidence from Anesthesia Rollups”
  • (Discussant) Abstract: “Price and Non-Price Effects of Physician Mergers and PE Acquisitions”
  • (Chair) Session: “Private Equity Rollups and Antitrust Implications”
  • (Chair) Session: “Pharmaceutical Procurement and Regulation”
Erin Trish, University of Southern California

23 June

  • (Author) Abstract: “Equity in Insulin Access and Health Outcomes after the Inflation Reduction Act’s Out-of-Pocket Spending Caps”

24 June

  • (Author) Abstract: “Hospital Prices Paid by Vertically Integrated Medicare Advantage Plans”

Cornerstone Research is a sponsor of this event, hosted by the American Society of Health Economists. For more information, please visit the event website.

Speakers

Laurence C. Baker

Laurence C. Baker

Professor of Health Policy,
Bing Professor of Human Biology,
Senior Fellow, Stanford Institute for Economic Policy Research,
Stanford University;
Associate Chair for Education, Department of Health Policy,
Stanford School of Medicine;
Senior Advisor, Cornerstone Research

M. Kate Bundorf

M. Kate Bundorf

J. Alexander McMahon Distinguished Professor of Health Policy and Management,
Sanford School of Public Policy,
Core Faculty Member, Duke-Margolis Center for Health Policy,
Duke University

Caitlyn Fleming
  • Location icon Silicon Valley
  • Email icon
  • Phone icon

Caitlyn Fleming

Manager

Gautam Gowrisankaran

Gautam Gowrisankaran

Professor of Economics,
Columbia University;
Senior Advisor, Cornerstone Research

Darius Lakdawalla

Darius Lakdawalla

Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, School of Pharmacy,
Professor, Sol Price School of Public Policy,
Chief Scientific Officer, Leonard D. Schaeffer Center for Health Policy and Economics,
University of Southern California

Sean Nicholson

Sean Nicholson

Professor, Department of Economics,
Professor, Brooks School of Public Policy,
Director, Sloan Program in Health Administration,
Cornell University;
Senior Advisor, Cornerstone Research

Maria Polyakova

Maria Polyakova

Associate Professor,
Department of Health Policy,
Stanford School of Medicine;
Senior Fellow, Stanford Institute of Economic Policy Research (SIEPR),
Stanford University

Michael R. Richards

Michael R. Richards

Professor,
Director, Sloan Program in Health Administration (M.H.A.),
Jeb E. Brooks School of Public Policy,
Cornell University

Amanda Starc

Amanda Starc

Associate Professor of Strategy,
Kellogg School of Management,
Northwestern University

Erin Trish

Erin Trish

Associate Professor,
Department of Pharmaceutical and Health Economics,
Mann School of Pharmacy and Pharmaceutical Sciences,
Co-Director, Leonard D. Schaeffer Center for Health Policy and Economics,
University of Southern California